{"license":"https://creativecommons.org/licenses/by/4.0/","dataset":"event-entities","count":6,"summary":{"policyEntityCount":21,"relationshipCount":31,"officialEventCount":14,"linkedEventCount":12,"unlinkedEventCount":2,"marketCount":7,"sourceCount":11,"agencyCount":4,"profileCrosswalkCount":6,"firstYear":2019,"latestYear":2026,"spanLabel":"2019-2026"},"guardrail":"A relationship means an official source names the organization in connection with the dated record. It does not by itself establish liability, market power, ownership, control, or that the organization participates in every market linked to that record.","crosswalkGuardrail":"Optional participant and operator crosswalks are observatory navigation aids based on matched public labels. They are not legal-entity, affiliate, beneficial-owner, or corporate-control determinations.","filters":{"source":"ftc-pbm-interim-2024","sourceMatched":true,"sourceId":"ftc-pbm-interim-2024","sourceTitle":"Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies","sourcePublisher":"Federal Trade Commission","sourceProfileHref":"/sources/ftc-pbm-interim-2024"},"rows":[{"id":"peel-caremark-report","eventId":"evt-pbm-interim-report-2024","eventDate":"2024-07-09","eventTitle":"FTC releases interim staff report on prescription drug middlemen","eventStage":"monitoring","eventType":"report","agency":"Federal Trade Commission","docketNumber":null,"entityId":"pent-caremark-rx","entitySlug":"caremark-rx-llc","entityName":"Caremark Rx, LLC","role":"report_subject","roleLabel":"Report subject","evidenceSummary":"The FTC interim report identifies Caremark Rx among the six PBMs that received Section 6(b) orders.","markets":[{"id":"mkt-pbm","slug":"us-pharmacy-benefit-management","name":"U.S. pharmacy benefit management"}],"sourceId":"ftc-pbm-interim-2024","sourceTitle":"Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies","sourcePublisher":"Federal Trade Commission","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/07/ftc-releases-interim-staff-report-prescription-drug-middlemen","sourceAccessDate":"2026-05-16","profileHref":null,"profileKind":null,"policyEntityProfileHref":"/enforcement/entities/caremark-rx-llc","recordProfileHref":"/enforcement/records/pbm-interim-report-2024","enforcementHref":"/enforcement?policyEntity=caremark-rx-llc&enforcementEvent=evt-pbm-interim-report-2024#enforcement-relationship-atlas","guardrail":"A relationship means an official source names the organization in connection with the dated record. It does not by itself establish liability, market power, ownership, control, or that the organization participates in every market linked to that record.","crosswalkGuardrail":"Optional participant and operator crosswalks are observatory navigation aids based on matched public labels. They are not legal-entity, affiliate, beneficial-owner, or corporate-control determinations.","sourceProfileHref":"/sources/ftc-pbm-interim-2024"},{"id":"peel-express-scripts-report","eventId":"evt-pbm-interim-report-2024","eventDate":"2024-07-09","eventTitle":"FTC releases interim staff report on prescription drug middlemen","eventStage":"monitoring","eventType":"report","agency":"Federal Trade Commission","docketNumber":null,"entityId":"pent-express-scripts","entitySlug":"express-scripts-inc","entityName":"Express Scripts, Inc.","role":"report_subject","roleLabel":"Report subject","evidenceSummary":"The FTC interim report identifies Express Scripts among the six PBMs that received Section 6(b) orders.","markets":[{"id":"mkt-pbm","slug":"us-pharmacy-benefit-management","name":"U.S. pharmacy benefit management"}],"sourceId":"ftc-pbm-interim-2024","sourceTitle":"Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies","sourcePublisher":"Federal Trade Commission","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/07/ftc-releases-interim-staff-report-prescription-drug-middlemen","sourceAccessDate":"2026-05-16","profileHref":null,"profileKind":null,"policyEntityProfileHref":"/enforcement/entities/express-scripts-inc","recordProfileHref":"/enforcement/records/pbm-interim-report-2024","enforcementHref":"/enforcement?policyEntity=express-scripts-inc&enforcementEvent=evt-pbm-interim-report-2024#enforcement-relationship-atlas","guardrail":"A relationship means an official source names the organization in connection with the dated record. It does not by itself establish liability, market power, ownership, control, or that the organization participates in every market linked to that record.","crosswalkGuardrail":"Optional participant and operator crosswalks are observatory navigation aids based on matched public labels. They are not legal-entity, affiliate, beneficial-owner, or corporate-control determinations.","sourceProfileHref":"/sources/ftc-pbm-interim-2024"},{"id":"peel-humana-report","eventId":"evt-pbm-interim-report-2024","eventDate":"2024-07-09","eventTitle":"FTC releases interim staff report on prescription drug middlemen","eventStage":"monitoring","eventType":"report","agency":"Federal Trade Commission","docketNumber":null,"entityId":"pent-humana-pharmacy-solutions","entitySlug":"humana-pharmacy-solutions-inc","entityName":"Humana Pharmacy Solutions, Inc.","role":"report_subject","roleLabel":"Report subject","evidenceSummary":"The FTC interim report identifies Humana Pharmacy Solutions among the six PBMs that received Section 6(b) orders.","markets":[{"id":"mkt-pbm","slug":"us-pharmacy-benefit-management","name":"U.S. pharmacy benefit management"}],"sourceId":"ftc-pbm-interim-2024","sourceTitle":"Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies","sourcePublisher":"Federal Trade Commission","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/07/ftc-releases-interim-staff-report-prescription-drug-middlemen","sourceAccessDate":"2026-05-16","profileHref":null,"profileKind":null,"policyEntityProfileHref":"/enforcement/entities/humana-pharmacy-solutions-inc","recordProfileHref":"/enforcement/records/pbm-interim-report-2024","enforcementHref":"/enforcement?policyEntity=humana-pharmacy-solutions-inc&enforcementEvent=evt-pbm-interim-report-2024#enforcement-relationship-atlas","guardrail":"A relationship means an official source names the organization in connection with the dated record. It does not by itself establish liability, market power, ownership, control, or that the organization participates in every market linked to that record.","crosswalkGuardrail":"Optional participant and operator crosswalks are observatory navigation aids based on matched public labels. They are not legal-entity, affiliate, beneficial-owner, or corporate-control determinations.","sourceProfileHref":"/sources/ftc-pbm-interim-2024"},{"id":"peel-medimpact-report","eventId":"evt-pbm-interim-report-2024","eventDate":"2024-07-09","eventTitle":"FTC releases interim staff report on prescription drug middlemen","eventStage":"monitoring","eventType":"report","agency":"Federal Trade Commission","docketNumber":null,"entityId":"pent-medimpact","entitySlug":"medimpact-healthcare-systems-inc","entityName":"MedImpact Healthcare Systems, Inc.","role":"report_subject","roleLabel":"Report subject","evidenceSummary":"The FTC interim report identifies MedImpact among the six PBMs that received Section 6(b) orders.","markets":[{"id":"mkt-pbm","slug":"us-pharmacy-benefit-management","name":"U.S. pharmacy benefit management"}],"sourceId":"ftc-pbm-interim-2024","sourceTitle":"Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies","sourcePublisher":"Federal Trade Commission","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/07/ftc-releases-interim-staff-report-prescription-drug-middlemen","sourceAccessDate":"2026-05-16","profileHref":null,"profileKind":null,"policyEntityProfileHref":"/enforcement/entities/medimpact-healthcare-systems-inc","recordProfileHref":"/enforcement/records/pbm-interim-report-2024","enforcementHref":"/enforcement?policyEntity=medimpact-healthcare-systems-inc&enforcementEvent=evt-pbm-interim-report-2024#enforcement-relationship-atlas","guardrail":"A relationship means an official source names the organization in connection with the dated record. It does not by itself establish liability, market power, ownership, control, or that the organization participates in every market linked to that record.","crosswalkGuardrail":"Optional participant and operator crosswalks are observatory navigation aids based on matched public labels. They are not legal-entity, affiliate, beneficial-owner, or corporate-control determinations.","sourceProfileHref":"/sources/ftc-pbm-interim-2024"},{"id":"peel-optumrx-report","eventId":"evt-pbm-interim-report-2024","eventDate":"2024-07-09","eventTitle":"FTC releases interim staff report on prescription drug middlemen","eventStage":"monitoring","eventType":"report","agency":"Federal Trade Commission","docketNumber":null,"entityId":"pent-optumrx","entitySlug":"optumrx-inc","entityName":"OptumRx, Inc.","role":"report_subject","roleLabel":"Report subject","evidenceSummary":"The FTC interim report identifies OptumRx among the six PBMs that received Section 6(b) orders.","markets":[{"id":"mkt-pbm","slug":"us-pharmacy-benefit-management","name":"U.S. pharmacy benefit management"}],"sourceId":"ftc-pbm-interim-2024","sourceTitle":"Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies","sourcePublisher":"Federal Trade Commission","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/07/ftc-releases-interim-staff-report-prescription-drug-middlemen","sourceAccessDate":"2026-05-16","profileHref":null,"profileKind":null,"policyEntityProfileHref":"/enforcement/entities/optumrx-inc","recordProfileHref":"/enforcement/records/pbm-interim-report-2024","enforcementHref":"/enforcement?policyEntity=optumrx-inc&enforcementEvent=evt-pbm-interim-report-2024#enforcement-relationship-atlas","guardrail":"A relationship means an official source names the organization in connection with the dated record. It does not by itself establish liability, market power, ownership, control, or that the organization participates in every market linked to that record.","crosswalkGuardrail":"Optional participant and operator crosswalks are observatory navigation aids based on matched public labels. They are not legal-entity, affiliate, beneficial-owner, or corporate-control determinations.","sourceProfileHref":"/sources/ftc-pbm-interim-2024"},{"id":"peel-prime-report","eventId":"evt-pbm-interim-report-2024","eventDate":"2024-07-09","eventTitle":"FTC releases interim staff report on prescription drug middlemen","eventStage":"monitoring","eventType":"report","agency":"Federal Trade Commission","docketNumber":null,"entityId":"pent-prime-therapeutics","entitySlug":"prime-therapeutics-llc","entityName":"Prime Therapeutics LLC","role":"report_subject","roleLabel":"Report subject","evidenceSummary":"The FTC interim report identifies Prime Therapeutics among the six PBMs that received Section 6(b) orders.","markets":[{"id":"mkt-pbm","slug":"us-pharmacy-benefit-management","name":"U.S. pharmacy benefit management"}],"sourceId":"ftc-pbm-interim-2024","sourceTitle":"Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies","sourcePublisher":"Federal Trade Commission","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/07/ftc-releases-interim-staff-report-prescription-drug-middlemen","sourceAccessDate":"2026-05-16","profileHref":null,"profileKind":null,"policyEntityProfileHref":"/enforcement/entities/prime-therapeutics-llc","recordProfileHref":"/enforcement/records/pbm-interim-report-2024","enforcementHref":"/enforcement?policyEntity=prime-therapeutics-llc&enforcementEvent=evt-pbm-interim-report-2024#enforcement-relationship-atlas","guardrail":"A relationship means an official source names the organization in connection with the dated record. It does not by itself establish liability, market power, ownership, control, or that the organization participates in every market linked to that record.","crosswalkGuardrail":"Optional participant and operator crosswalks are observatory navigation aids based on matched public labels. They are not legal-entity, affiliate, beneficial-owner, or corporate-control determinations.","sourceProfileHref":"/sources/ftc-pbm-interim-2024"}]}